Community Health Systems (CYH)
(Delayed Data from NYSE)
$3.29 USD
-0.10 (-2.95%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $3.29 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Community Health Systems, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 12,490 | 12,211 | 12,368 | 11,789 | 13,210 |
Cost Of Goods | 1,993 | 1,975 | 2,042 | 1,963 | 2,151 |
Gross Profit | 10,497 | 10,236 | 10,326 | 9,826 | 11,059 |
Selling & Adminstrative & Depr. & Amort Expenses | 9,540 | 9,415 | 8,924 | 8,700 | 10,409 |
Income After Depreciation & Amortization | 957 | 821 | 1,402 | 1,126 | 650 |
Non-Operating Income | 80 | 386 | -18 | 327 | -39 |
Interest Expense | 830 | 858 | 885 | 1,031 | 1,041 |
Pretax Income | 207 | 349 | 499 | 422 | -430 |
Income Taxes | 191 | 170 | 131 | -185 | 160 |
Minority Interest | 149 | 133 | 138 | 96 | 85 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 16 | 179 | 368 | 607 | -590 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -133 | 46 | 230 | 511 | -675 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,462 | 1,355 | 1,942 | 1,684 | 1,258 |
Depreciation & Amortization (Cash Flow) | 505 | 534 | 540 | 558 | 608 |
Income After Depreciation & Amortization | 957 | 821 | 1,402 | 1,126 | 650 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 130.00 | 130.00 | 131.00 | 117.00 | 114.00 |
Diluted EPS Before Non-Recurring Items | -1.39 | -1.38 | 2.45 | 0.45 | -0.89 |
Diluted Net EPS (GAAP) | -1.02 | 0.35 | 1.76 | 4.39 | -5.93 |
Fiscal Year end for Community Health Systems, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 3,140.00 | 3,181.00 | 3,086.00 | 3,115.00 | 3,108.00 |
Cost Of Goods | 487.00 | 493.00 | 489.00 | 504.00 | 507.00 |
Gross Profit | 2,653.00 | 2,688.00 | 2,597.00 | 2,611.00 | 2,601.00 |
SG&A, R&D, and Dept/Amort Expenses | 2,422.00 | 2,360.00 | 2,424.00 | 2,365.00 | 2,391.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 231.00 | 328.00 | 173.00 | 246.00 | 210.00 |
Non-Operating Income | 2.00 | 2.00 | 2.00 | 1.00 | 3.00 |
Interest Expense | 211.00 | 208.00 | 208.00 | 207.00 | 207.00 |
Pretax Income | 22.00 | 194.00 | -33.00 | 40.00 | 6.00 |
Income Taxes | 28.00 | 108.00 | 19.00 | 38.00 | 26.00 |
Minority Interest | 35.00 | 39.00 | 39.00 | 40.00 | 31.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.00 | 86.00 | -52.00 | 2.00 | -20.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -41.00 | 47.00 | -91.00 | -38.00 | -51.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 131.00 | 132.00 | 131.00 | 131.00 | 130.00 |
Diluted EPS Before Non-Recurring Items | -0.14 | -0.41 | -0.33 | -0.22 | -0.43 |
Diluted Net EPS (GAAP) | -0.32 | 0.36 | -0.69 | -0.29 | -0.40 |